Skip to main content
博迅生物 logo

博迅生物 — Investor Relations & Filings

Ticker · 920504 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 301 across all filing types
Latest filing 2026-02-04 Audit Report / Informat…
Country CN China
Listing Beijing Stock Exchange 920504

About 博迅生物

http://www.boxun.com.cn/

Boxun Medical Biological Instrument Corp. specializes in the development and manufacture of laboratory equipment and medical instruments. The company's core product line includes high-pressure steam sterilizers, constant temperature incubators, CO2 incubators, drying ovens, and environmental test chambers. These instruments are designed for applications in life sciences, healthcare, pharmaceutical research, and environmental monitoring. Boxun focuses on delivering precise thermal control and reliable sterilization solutions, ensuring compliance with international quality standards. Its equipment is utilized in scientific research, clinical diagnostics, and industrial quality control to maintain sterile environments and stable experimental conditions. The company emphasizes technical innovation and product durability to support the requirements of modern laboratory facilities.

Recent filings

Filing Released Lang Actions
国金证券股份有限公司关于上海博迅医疗生物仪器股份有限公司使用自有资金支付募投项目人员费用并以募集资金等额置换的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed verification opinion from Guojin Securities regarding the use of self-owned funds to pay personnel expenses for a fundraising project by Shanghai Boxun Medical Biological Instruments Co., Ltd., and the subsequent replacement of these funds with raised capital. It references regulatory approvals, fundraising details, usage of funds, and compliance with relevant securities regulations. The document includes financial figures related to fundraising and usage but does not present a full financial report or comprehensive financial statements. It is a specialized verification or audit opinion related to fundraising and fund usage compliance, not a full annual or interim report, earnings release, or other financial report. The document length is 3114 characters, which is relatively short and focused on a specific verification matter. This fits best with an Audit Report / Information (AR) category, which covers standalone audit reports and verification opinions related to accounting and regulatory compliance, excluding full annual reports. Therefore, the classification is AR with high confidence. Q1 2026
2026-02-04 Chinese
关于使用自有资金支付募投项目人员费用并以募集资金等额置换的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from Shanghai Boxun Medical Biological Instrument Co., Ltd. regarding the use of self-owned funds to pay personnel expenses for a fundraising investment project and the equivalent replacement with raised funds. It details the fundraising amount, usage progress, regulatory compliance, board approval, and supervisory opinions. The document is a specific announcement about the company's capital usage and fundraising project management, not a full financial report or audit. It does not contain comprehensive financial statements or quarterly results but focuses on capital management and compliance with fundraising regulations. Therefore, it fits best under Capital/Financing Update (CAP). The document length is under 5,000 characters and contains detailed content, so it is not a mere report publication announcement or regulatory filing. Hence, the classification is CAP with high confidence.
2026-02-04 Chinese
关于使用闲置募集资金进行现金管理的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the use of idle raised funds for cash management by Shanghai BoXun Medical Biological Instrument Co., Ltd. It details the fundraising amount, usage progress, investment products, decision-making process, risk control measures, and the impact on the company. It includes a board resolution and a sponsor's opinion but does not contain financial statements or detailed financial performance data. The document is relatively short (3054 characters) and serves as a disclosure about the company's capital management activities rather than a full financial report or earnings release. Therefore, it fits best under Capital/Financing Update (CAP).
2026-02-04 Chinese
募投项目延期公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Shanghai Boxun Medical Biological Instrument Co., Ltd. regarding the delay of fundraising investment projects. It details the original fundraising, usage of funds, reasons for project delays, and revised timelines. The document includes specifics about the fundraising amount, project progress, and regulatory compliance references. It is not a full financial report but an update on capital project progress and fundraising usage. The document length is 4599 characters, which is borderline but contains substantive content about fundraising and project status rather than just announcing a report. This fits the definition of a Capital/Financing Update (CAP) as it provides updates on company fundraising and capital usage changes, specifically about project delays and fund deployment. Therefore, the appropriate classification is CAP with high confidence.
2026-02-04 Chinese
关于使用闲置自有资金购买理财产品的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Shanghai BoXun Medical Biological Instruments Co., Ltd. regarding the use of idle own funds to purchase financial products. It details the purpose, amount, method, duration, decision-making process, risk analysis, impact on the company, and opinions from intermediary institutions. The document is a formal disclosure about financing activities related to the company's capital management but does not contain financial statements or earnings data. It is not a full financial report, earnings release, or management discussion. It fits the category of Capital/Financing Update (CAP) as it updates on the company's financing activities involving the use of idle funds for investment in financial products.
2026-02-04 Chinese
关于向银行申请授信额度的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Shanghai Boxun Medical Biological Instruments Co., Ltd. regarding the application for a bank credit line (授信额度). It details the credit amount, purpose, authorization for management to sign contracts, and the board meeting resolution approving the credit application. There are no financial statements, audit opinions, or detailed financial data presented. The document is a formal announcement about financing activities, specifically about applying for bank credit facilities. This fits the definition of a Capital/Financing Update (CAP). The document length is short and contains substantive content about financing, so it is not a mere report publication announcement or regulatory filing. Therefore, the correct classification is CAP with high confidence.
2026-02-04 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.